- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CBPO Market Currents
more »
-
July 15, 2011 China Biologic Products (CBPO -6.5%) takes a hit today after receiving notification from the Guizhou Provincial Health Department that the government has suspended the company's blood collection activities in the province. The suspension affects four of six collection sites it runs, and the impact upon current business operations could be significant.
Comment![Healthcare, Global & FX, On the Move]
CBPO in Focus
more »
CBPO Related Articles
more »
CBPO News
more »
Currently, there are no news on CBPO.
CBPO Press Releases and Filings
more »
-
PR Newswire (May 11, 2012)
-
PR Newswire (May 8, 2012)
-
PR Newswire (May 7, 2012)
-
PR Newswire (Apr 27, 2012)
-
PR Newswire (Apr 25, 2012)
CBPO Latest Transcript
more »
Currently, there are no transcripts for CBPO.
CBPO Cramer
more »
Currently, there are no Cramer articles on CBPO.
CBPO Instablog posts
more »
CBPO vs. ETF Alternatives
Company Description
Currently, there's no company description for CBPO.